Innate Pharma
IPHA
#8351
Rank
A$0.26 B
Marketcap
$3.09
Share price
0.00%
Change (1 day)
-17.85%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -A$13.08 Million

According to Innate Pharma 's latest financial reports the company's current earnings are A$57.37 Million. In 2023 the company made an earning of -A$13.08 Million, an increase over its 2022 earnings that were of -A$97.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-A$13.08 Million-86.54%
2022-A$97.2 Million20.74%
2021-A$80.51 Million4951.09%
2020-A$1.6 Million-111.57%
2019A$13.77 M183.46%
2018A$4.85 M-105.4%
2017-A$90.05 Million-523.25%
2016A$21.27 M-285.64%
2015-A$11.47 Million-69.31%
2014-A$37.35 Million498.29%
2013-A$6.25 Million-5.62%
2012-A$6.62 Million-53.32%
2011-A$14.17 Million-50.1%
2010-A$28.4 Million-13.3%
2009-A$32.76 Million26.36%
2008-A$25.92 Million27.35%
2007-A$20.36 Million63.33%
2006-A$12.47 Million9.81%
2005-A$11.35 Million